STEP Business R&D&I for Digital and Biotechnology is a funding instrument designed to support integrated Research, Development and Innovation projects in digital, deep-tech and biotechnology sectors. It focuses on strengthening value chains by promoting innovation projects that progress from advanced development stages to commercial deployment.
Programme details
Application deadline: Expected deadline September 2026
Beneficiary entities: Large companies, SMEs, micro-enterprises and startups
Benefit: Max 80% non-refundable grant
Geographic scope: Mainland Portugal (excluding Lisbon area)
About the funding
STEP Business R&D&I for Digital and Biotechnology is a funding incentive that promotes critical technologies in the digital, deep-tech and biotechnology sectors.
This call supports integrated Research, Development and Innovation (R&D&I) projects, covering the full innovation cycle, from development stages through to commercial application. The objective is to preserve and strengthen national value chains by supporting technologically advanced and knowledge-intensive projects.
Operations may include high Technology Readiness Level (TRL) developments, leading to the commercial production and market introduction of new technologies.
How it works
This incentive is designed to support business-driven R&D&I projects that combine technological development with innovation and market readiness.
Projects must demonstrate the integration of research and innovation activities within critical technology areas, contributing to:
The development and maturation of digital, deep-tech and biotechnology solutions
The reinforcement of national value chains
The transition from advanced development stages to commercial production
Beneficiaries may include companies of all sizes, as well as ENESII entities acting as partners within the projects.
Eligible investment expenses
Eligible expenses under STEP Business R&D&I for Digital and Biotechnology include:
Projects that integrate Research, Development and Innovation activities
Investments directly related to critical digital, deep-tech and biotechnology sectors
Only expenses that are clearly linked to R&D&I activities and technological development within the scope of the project are considered eligible.
Who can benefit from this incentive
STEP Business R&D&I for Digital and Biotechnology is aimed at organisations involved in the development of critical technologies, including:
Companies of any size developing R&D&I projects
Entities participating in innovation ecosystems and value chains
ENESII entities acting as project partners
The incentive is particularly relevant for projects that bridge advanced development stages and commercial deployment.
Understanding the rules and eligibility criteria of each incentive is essential to assess its relevance and potential impact within a company’s broader investment and tax strategy.
For clarification or further information, reach out through our contact form.
